STERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow STE
STERIS plc (STE) Return on equity
STERIS plc's return on equity over the twelve months to 30 June 2026 was 11.4%, up 0.0 percentage points from fiscal 2026 (11.3%). Over the past ten years it has ranged from 1.69% (fiscal 2023) to 12.8% (fiscal 2015); the current reading is higher than 83% of that period. That is above the Medical Devices industry median of −15.3% and above the Healthcare sector median of −31.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2026 | 11.3% | 1.82 |
| FY2025 | 9.51% | 3.41 |
| FY2024 | 6.10% | 4.41 |
| FY2023 | 1.69% | (2.98) |
| FY2022 | 4.67% | (6.20) |
| FY2021 | 10.9% | (1.48) |
| FY2020 | 12.4% | 2.86 |
| FY2019 | 9.49% | (0.16) |
| FY2018 | 9.65% | 5.89 |
| FY2017 | 3.76% | (1.63) |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| DXCM DexCom, Inc. compare | 38.5% |
| GEHC GE HealthCare Technologies Inc. compare | 19.2% |
| GMED Globus Medical, Inc. compare | 11.8% |
| PEN Penumbra, Inc. compare | 11.4% |
| STE STERIS plc | 11.4% |
| PHG Koninklijke Philips N.V. compare | 10.2% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.41% |
| BIO.B Bio-Rad Laboratories, Inc. compare | 3.11% |
| SNN Smith & Nephew SNATS, Inc. compare | 0.00% |
| Medical Devices industry median | −15.3% |
| Healthcare sector median | −31.3% |
| Market median | 1.35% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement